Yokoi T - Search Results

1

Enhancement of cytochrome P-450 3A4 catalytic activities by cytochrome b(5) in bacterial membranes.

Yamazaki H, Nakajima M, Nakamura M, Asahi S, Shimada N, Gillam EM, Guengerich FP, Shimada T, Yokoi T. Yamazaki H, et al. Among authors: yokoi t. Drug Metab Dispos. 1999 Sep;27(9):999-1004. Drug Metab Dispos. 1999. PMID: 10460798

2

Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes.

Nakajima M, Ohyama K, Nakamura S, Shimada N, Yamazaki H, Yokoi T. Nakajima M, et al. Among authors: yokoi t. Drug Metab Dispos. 1999 Jul;27(7):792-7. Drug Metab Dispos. 1999. PMID: 10383922

3

Involvement of CYP2E1 as A low-affinity enzyme in phenacetin O-deethylation in human liver microsomes.

Kobayashi K, Nakajima M, Oshima K, Shimada N, Yokoi T, Chiba K. Kobayashi K, et al. Among authors: yokoi t. Drug Metab Dispos. 1999 Aug;27(8):860-5. Drug Metab Dispos. 1999. PMID: 10421611

4

Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes.

Yamazaki H, Shibata A, Suzuki M, Nakajima M, Shimada N, Guengerich FP, Yokoi T. Yamazaki H, et al. Among authors: yokoi t. Drug Metab Dispos. 1999 Nov;27(11):1260-6. Drug Metab Dispos. 1999. PMID: 10534310

5

Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs.

Nakajima M, Nakamura S, Tokudome S, Shimada N, Yamazaki H, Yokoi T. Nakajima M, et al. Among authors: yokoi t. Drug Metab Dispos. 1999 Dec;27(12):1381-91. Drug Metab Dispos. 1999. PMID: 10570018

6

In vitro inhibitory effects of troglitazone and its metabolites on drug oxidation activities of human cytochrome P450 enzymes: comparison with pioglitazone and rosiglitazone.

Yamazaki H, Suzuki M, Tane K, Shimada N, Nakajima M, Yokoi T. Yamazaki H, et al. Among authors: yokoi t. Xenobiotica. 2000 Jan;30(1):61-70. doi: 10.1080/004982500237820. Xenobiotica. 2000. PMID: 10659951

7

Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.

Katoh M, Nakajima M, Shimada N, Yamazaki H, Yokoi T. Katoh M, et al. Among authors: yokoi t. Eur J Clin Pharmacol. 2000 Feb-Mar;55(11-12):843-52. doi: 10.1007/s002280050706. Eur J Clin Pharmacol. 2000. PMID: 10805063

8

A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor.

Ohyama K, Nakajima M, Nakamura S, Shimada N, Yamazaki H, Yokoi T. Ohyama K, et al. Among authors: yokoi t. Drug Metab Dispos. 2000 Nov;28(11):1303-10. Drug Metab Dispos. 2000. PMID: 11038157

9

Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4.

Komatsu T, Yamazaki H, Asahi S, Gillam EM, Guengerich FP, Nakajima M, Yokoi T. Komatsu T, et al. Among authors: yokoi t. Drug Metab Dispos. 2000 Nov;28(11):1361-8. Drug Metab Dispos. 2000. PMID: 11038165

10

Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes.

Komatsu T, Yamazaki H, Shimada N, Nakajima M, Yokoi T. Komatsu T, et al. Among authors: yokoi t. Drug Metab Dispos. 2000 Dec;28(12):1457-63. Drug Metab Dispos. 2000. PMID: 11095583

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,305 results

Search Page

Filters